These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36822274)

  • 1. Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry.
    Solanki R; Wadhwana P; Patel R; Gayakvad B; Kothari C; Patel C
    J Pharm Sci; 2023 May; 112(5):1268-1276. PubMed ID: 36822274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous analysis of carcinogenic N-nitrosamine impurities in metformin tablets using on-line in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry.
    Ishizaki A; Ozawa K; Kataoka H
    J Chromatogr A; 2023 Nov; 1710():464416. PubMed ID: 37804578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an analytical method for trace-level quantification of genotoxic nitrosamine impurities in losartan and hydrochlorothiazide fixed-dose combination tablets using ultra performance liquid chromatography triple quadrupole mass spectrometry.
    Patel R; Purohit S; Solanki R; Khunt D; Patel C; Patel R; Parikh S
    Rapid Commun Mass Spectrom; 2023 Apr; 37(8):e9488. PubMed ID: 36740827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory Updates and Analytical Methodologies for Nitrosamine Impurities Detection in Sartans, Ranitidine, Nizatidine, and Metformin along with Sample Preparation Techniques.
    Shaik KM; Sarmah B; Wadekar GS; Kumar P
    Crit Rev Anal Chem; 2022; 52(1):53-71. PubMed ID: 32691615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A GC-MS/MS Method for Trace Level Quantification of Six Nitrosamine Impurities (NDMA, NDEA, NEIPA, NDIPA, NDPA, and NDBA) in Commercially Used Organic Solvents: Dichloromethane, Ethyl Acetate, Toluene, and O-xylene.
    Kosuri ER; Bhanti M; Jaywant MA; Han M; Wang X; Obeng M
    J Pharm Sci; 2023 May; 112(5):1225-1230. PubMed ID: 36462706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multi-Analyte LC-MS/MS Method for Determination and Quantification of Six Nitrosamine Impurities in Sartans like Azilsartan, Valsartan, Telmisartan, Olmesartan, Losartan and Irbesartan.
    Gopireddy RR; Maruthapillai A; Mahapatra S
    J Chromatogr Sci; 2024 Feb; 62(2):147-167. PubMed ID: 35830866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Analytical Method for Determining N-Nitrosodimethylamine and N-Nitrosodiethylamine Contamination in Irbesartan, Olmesartan and Metformin by UPLC-APCI-MS/MS in Tablet Dosage Form.
    Deeb AA; Hailat M; Aldoqum HM; Abuothman M; Abuyaman O; Abu Dayyih W
    J Chromatogr Sci; 2024 Apr; 62(4):372-379. PubMed ID: 37622601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive detection of antidiabetic compounds and one degradation product in wastewater samples by a new SPE-LC-MS/MS method.
    Iancu VI; Scutariu RE; Chiriac FL; Radu GL
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2021; 56(3):310-323. PubMed ID: 33471573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of 13 nitrosamine impurities in biological medicines using salting-out liquid-liquid extraction coupled with liquid chromatography tandem mass spectrometry.
    Luo F; Liu Y; Xie Y; Hou W; Zhang L; Zhang Z
    J Pharm Biomed Anal; 2022 Sep; 218():114867. PubMed ID: 35679708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS/MS Investigation of nitrosamine impurities in certain Sartan group medicinal products available in Istanbul, Türkiye.
    Öncü T; Yüksel B; Binay E; Şen N
    Ann Pharm Fr; 2024 Jan; 82(1):72-83. PubMed ID: 37567559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of metformin and glipizide in human plasma by liquid chromatography-tandem mass spectrometry.
    Ding CG; Zhou Z; Ge QH; Zhi XJ; Ma LL
    Biomed Chromatogr; 2007 Feb; 21(2):132-8. PubMed ID: 17221919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of genotoxic N-nitrosamines in active pharmaceutical ingredients and market authorized products in low abundance by means of liquid chromatography - tandem mass spectrometry.
    Vogel M; Norwig J
    J Pharm Biomed Anal; 2022 Sep; 219():114910. PubMed ID: 35779354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices.
    Manchuri KM; Shaik MA; Gopireddy VSR; Naziya Sultana ; Gogineni S
    Chem Res Toxicol; 2024 Sep; 37(9):1456-1483. PubMed ID: 39158368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method for trace determination of N-nitrosamines impurities in metronidazole benzoate using high-performance liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry.
    Yin M; Hu Y; Fan H; Wang Q; Wang M; Wang W; Shi C
    J Sep Sci; 2023 Mar; 46(5):e2200225. PubMed ID: 36562102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a sensitive LC-APCI-MS/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach.
    Mavis ME; Goksu Gursu G; Ular Cagatay N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123593. PubMed ID: 36669257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of
    Guo C; Liu Q; Zhang L; Zheng J; Wang Y; Yang S; Chu Z; Niu C; Xu Y
    Se Pu; 2020 Nov; 38(11):1288-1293. PubMed ID: 34213099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel method for monitoring of carcinogenic impurity of N-nitrosamine in nizatidine pharmaceutical products using ultra high-pressure liquid chromatography triple quadrupole mass spectrometry.
    Dhorajiya S; Goswami J; Dudhatra B; Thummar K
    Rapid Commun Mass Spectrom; 2024 Oct; 38(19):e9884. PubMed ID: 39129244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl-Biphenyl-Tetrazole Impurities in Losartan.
    Luan NM; Khuyen VTK; Tuan ND
    J Sep Sci; 2024 Oct; 47(19):e202400277. PubMed ID: 39385440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and optimization of a HS-SPME-assisted GC-MS/MS method for monitoring nitrosamine impurities in diverse pharmaceuticals.
    Chang SH; Ho HY; Chang CC; Zang CZ; Hsu YH; Lin MC; Tseng SH; Wang DY
    J Pharm Biomed Anal; 2022 Nov; 221():115003. PubMed ID: 36095885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.